Who Buys Vinorelbine from India — 138 Importers Behind a $3.4M Market
India's vinorelbine import market is served by 138 active buyers who collectively imported $3.4M across 439 shipments. BROCACEF NL : HUB (NETHERLANDS) leads with a 14.4% market share, followed by EUGIA PHARMA (MALTA) LTD, and ATCO PHARMA INTERNATIONAL PVT LTD. The top 5 buyers together control 43.8% of total import value, reflecting a moderately competitive buyer landscape.
Vinorelbine buyer data — 138 importers · $3.4M market · 439 shipmentsTransData Nexus · Indian Customs Data
Top Vinorelbine Importers — Ranked by Import Value
BROCACEF NL : HUB (NETHERLANDS) is the leading vinorelbine importer from India, holding a 14.4% share of the $3.4M market across 439 shipments from 138 buyers. The top 5 buyers — BROCACEF NL : HUB (NETHERLANDS), EUGIA PHARMA (MALTA) LTD, (MALTA), ATCO PHARMA INTERNATIONAL PVT LTD (PAKISTAN), ACCORD HEALTHCARE POLSKA SP. Z.O.O. (POLAND), ACCORD HEALTHCARE POLSKA SP. Z O.O. (POLAND) — collectively control 43.8% of total import value.
Top Vinorelbine Buyers & Importers
Ranked by import value · 138 active buyers · Indian Customs (DGFT) data
Apr 2026
Top Vinorelbine Buyers & Importers — Ranked by Import Value. 138 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Vinorelbine — and from which countries?
Flow of Vinorelbine exports from India: each country's share and the named importers behind the numbers
Vinorelbine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 73.2% of global Vinorelbine imports — led by Malta (22.9%) with a total trade value of $3.4M across 439 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Malta
Malta emerges as the first largest importing country, achieving a total trade value of $776.6K through 19 shipments. This represents a market share of 22.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malta has a diverse importer base, with their top importers including:
• EUGIA PHARMA (MALTA) LTD, - $416.4K (53.6% of country's total business)
• EUGIA PHARMA (MALTA) LIMITED, - $88.6K (11.4% of country's total business)
• APL SWIFT SERVICES (MALTA) LIMITED - $80.7K (10.4% of country's total business)
Key Insight: Malta demonstrates strong market positioning with an average shipment value of $40.9K, indicating premium pricing strategy compared to the market average of $7.7K.
Malta is a key market for Vinorelbine imports, representing 22.9% of total trade value.
Primary Market
Secondary Market
2Netherlands
Netherlands emerges as the second largest importing country, achieving a total trade value of through . This represents a market share of of the total market activity, demonstrating their significant presence in the industry.
Vinorelbine, an anticancer agent, is imported from India by various entities, each with distinct procurement behaviors:
Distributors: Entities like BROCACEF NL : HUB in the Netherlands and BOTTU S.A in Morocco function as intermediaries, purchasing Vinorelbine in bulk to supply to healthcare providers. Their order patterns are characterized by large, periodic purchases aligned with market demand and inventory management strategies.
Contract Manufacturers: Companies such as EUGIA PHARMA (MALTA) LTD and APL SWIFT SERVICES (MALTA) LIMITED in Malta, and ATCO PHARMA INTERNATIONAL PVT LTD in Pakistan, procure Vinorelbine as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is driven by production schedules and regulatory approvals, leading to consistent and sizable orders.
Hospital Groups: Organizations like ACCORD HEALTHCARE POLSKA SP. Z.O.O. in Poland import Vinorelbine directly for use within their network of hospitals. Their purchasing behavior involves regular, smaller orders to maintain adequate stock levels for patient treatment needs.
Government Procurement: Institutions such as the CENTRE NATIONAL DE LUTTE CONTRE LE in Congo engage in tender-based procurement processes to acquire Vinorelbine for public healthcare facilities. Their purchasing patterns are influenced by budget cycles, disease prevalence, and national health priorities, often resulting in large, infrequent orders.
The top five importing countries of Vinorelbine from India—Malta, the Netherlands, Poland, Pakistan, and Venezuela—each have distinct regulatory frameworks:
Malta:
Regulatory Authority: Malta Medicines Authority (MMA).
Import Registration Process: Applicants must submit a Marketing Authorization Application (MAA) to the MMA, including comprehensive data on quality, safety, and efficacy.
Estimated Timeline: Approximately 210 days, subject to completeness of the application.
Import Tariff/Duty: As an EU member, Malta applies the EU's Common External Tariff; for HS Code 30049049, the duty is 0%.
The demand for Vinorelbine in importing countries is influenced by several key factors:
Disease Prevalence: Vinorelbine is primarily used in the treatment of non-small cell lung cancer and metastatic breast cancer. Countries with higher incidences of these cancers exhibit increased demand for the drug.
Government Healthcare Programs: National health initiatives aimed at improving cancer care, such as Pakistan's expanded healthcare coverage under the Sehat Sahulat Program, have led to increased procurement of oncology drugs, including Vinorelbine.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage, as seen in Venezuela's Barrio Adentro program, have expanded access to essential medicines, driving demand for treatments like Vinorelbine.
WHO Essential Medicines List Procurement: Inclusion of Vinorelbine in the WHO Essential Medicines List encourages its procurement by member states, ensuring availability in public health systems.
Common Questions — Vinorelbine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest vinorelbine buyer importing from India?
Based on import volume and value, BROCACEF NL : HUB (NETHERLANDS) leads with $486.5K in imports and a 14.4% market share — the highest of any single vinorelbine importer. EUGIA PHARMA (MALTA) LTD, (MALTA) and ATCO PHARMA INTERNATIONAL PVT LTD (PAKISTAN) are the next largest buyers.
QHow many companies buy vinorelbine from India?
There are 138 active vinorelbine buyers importing from India, with a combined market of $3.4M across 439 shipments to 60 countries. The top 5 buyers hold 43.8% of total import value, while the remaining 133 buyers handle the other 56.2%.
QWhich countries import the most vinorelbine from India?
The top importing countries for vinorelbine from India are Malta (22.9%), Netherlands (19.8%), Poland (14.7%), Pakistan (10.1%), Venezuela (5.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of vinorelbine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
Vinorelbine, an anticancer agent, is imported from India by various entities, each with distinct procurement behaviors:
Distributors: Entities like BROCACEF NL : HUB in the Netherlands and BOTTU S.A in Morocco function as intermediaries, purchasing Vinorelbine in bulk to supply to healthcare providers. Their order patterns are characterized by large, periodic purchases aligned with market demand and inventory management strategies.
Contract Manufacturers: Companies such as EUGIA PHARMA (MALTA) LTD and APL SWIFT SERVICES (MALTA) LIMITED in Malta, and ATCO PHARMA INTERNATIONAL PVT LTD in Pakistan, procure Vinorelbine as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is driven by production schedules and regulatory approvals, leading to consistent and sizable orders.
Hospital Groups: Organizations like ACCORD HEALTHCARE POLSKA SP. Z.O.O. in Poland import Vinorelbine directly for use within their network of hospitals. Their purchasing behavior involves regular, smaller orders to maintain adequate stock levels for patient treatment needs.
Government Procurement: Institutions such as the CENTRE NATIONAL DE LUTTE CONTRE LE in Congo engage in tender-based procurement processes to acquire Vinorelbine for public healthcare facilities. Their purchasing patterns are influenced by budget cycles, disease prevalence, and national health priorities, often resulting in large, infrequent orders.
The top five importing countries of Vinorelbine from India—Malta, the Netherlands, Poland, Pakistan, and Venezuela—each have distinct regulatory frameworks:
Malta:
Regulatory Authority: Malta Medicines Authority (MMA).
Import Registration Process: Applicants must submit a Marketing Authorization Application (MAA) to the MMA, including comprehensive data on quality, safety, and efficacy.
Estimated Timeline: Approximately 210 days, subject to completeness of the application.
Import Tariff/Duty: As an EU member, Malta applies the EU's Common External Tariff; for HS Code 30049049, the duty is 0%.
The demand for Vinorelbine in importing countries is influenced by several key factors:
Disease Prevalence: Vinorelbine is primarily used in the treatment of non-small cell lung cancer and metastatic breast cancer. Countries with higher incidences of these cancers exhibit increased demand for the drug.
Government Healthcare Programs: National health initiatives aimed at improving cancer care, such as Pakistan's expanded healthcare coverage under the Sehat Sahulat Program, have led to increased procurement of oncology drugs, including Vinorelbine.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage, as seen in Venezuela's Barrio Adentro program, have expanded access to essential medicines, driving demand for treatments like Vinorelbine.
WHO Essential Medicines List Procurement: Inclusion of Vinorelbine in the WHO Essential Medicines List encourages its procurement by member states, ensuring availability in public health systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
$670.2K
52 shipments
19.8%
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• BROCACEF NL : HUB - $486.5K (72.6% of country's total business)
• BROCACEF NL:HUB - $76.5K (11.4% of country's total business)
• BROCACEF NL HUB BROCACEF HEALTHCAR - $45.3K (6.8% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $12.9K, indicating premium pricing strategy compared to the market average of $7.7K.
Netherlands is a key market for Vinorelbine imports, representing 19.8% of total trade value.
Primary Market
Secondary Market
3Poland
Poland emerges as the third largest importing country, achieving a total trade value of $496.8K through 23 shipments. This represents a market share of 14.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Poland has a diverse importer base, with their top importers including:
• ACCORD HEALTHCARE POLSKA SP. Z.O.O. - $205.0K (41.3% of country's total business)
• ACCORD HEALTHCARE POLSKA SP. Z O.O. - $127.6K (25.7% of country's total business)
• ACCORD HEALTHCARE POLSKA SP.Z.O.O. - $96.3K (19.4% of country's total business)
• ACCORD HEALTHCARE POLSKA SP ZOO MAGAZYN IMPORTERA UL LUTOMIERSKA - $67.9K (13.7% of country's total business)
Key Insight: Poland demonstrates strong market positioning with an average shipment value of $21.6K, indicating premium pricing strategy compared to the market average of $7.7K.
Poland is a key market for Vinorelbine imports, representing 14.7% of total trade value.
Primary Market
Secondary Market
4Pakistan
Pakistan emerges as the fourth largest importing country, achieving a total trade value of $341.2K through 3 shipments. This represents a market share of 10.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Pakistan has a diverse importer base, with their top importers including:
• ATCO PHARMA INTERNATIONAL PVT LTD - $248.6K (72.8% of country's total business)
Key Insight: Pakistan demonstrates strong market positioning with an average shipment value of $113.7K, indicating premium pricing strategy compared to the market average of $7.7K.
Pakistan is a key market for Vinorelbine imports, representing 10.1% of total trade value.
Primary Market
Secondary Market
5Venezuela
Venezuela emerges as the fifth largest importing country, achieving a total trade value of $195.0K through 0 shipments. This represents a market share of 5.8% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Venezuela demonstrates strong market positioning with an average shipment value of $195.0K, indicating premium pricing strategy compared to the market average of $7.7K.
Venezuela is a key market for Vinorelbine imports, representing 5.8% of total trade value.
Primary Market
Secondary Market
Understanding these segments is crucial for suppliers aiming to tailor their strategies to meet the specific needs and procurement behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Submission of a MAA to the MEB, with requirements similar to those of the European Medicines Agency (EMA).
Estimated Timeline: Approximately 210 days.
Import Tariff/Duty: As part of the EU, the Netherlands applies a 0% duty for HS Code 30049049.
Poland:
Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
Import Registration Process: MAA submission to URPL, aligning with EU directives.
Estimated Timeline: Approximately 210 days.
Import Tariff/Duty: As an EU member, Poland applies a 0% duty for HS Code 30049049.
Pakistan:
Regulatory Authority: Drug Regulatory Authority of Pakistan (DRAP).
Import Registration Process: Submission of a registration dossier to DRAP, including product details, manufacturing information, and clinical data.
Estimated Timeline: 6 to 12 months, depending on the product category.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are typically subject to a 5% customs duty, with potential exemptions for essential medicines.
Venezuela:
Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).
Import Registration Process: Submission of a sanitary registration application to INHRR, including quality, safety, and efficacy data.
Estimated Timeline: 12 to 18 months, subject to regulatory review processes.
Import Tariff/Duty: Pharmaceutical imports may be subject to duties ranging from 5% to 15%, depending on the product classification and trade agreements.
Navigating these regulatory landscapes requires thorough preparation and compliance with each country's specific requirements to ensure successful market entry.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many countries utilize competitive tendering processes for pharmaceutical procurement. This approach can lead to increased demand for Vinorelbine, as suppliers compete to offer the best value for large-scale purchases.
With 138 buyers across 60 countries, the global demand for Vinorelbine reflects a combination of disease burden, healthcare policy initiatives, and procurement strategies aimed at enhancing cancer treatment accessibility.
TransData Nexus Research · Government and regulatory sourcesMar 2026
QWhat is the average import order value for vinorelbine from India?
The average import transaction value for vinorelbine from India is $7.7K, with an average unit price of $21.45 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Understanding these segments is crucial for suppliers aiming to tailor their strategies to meet the specific needs and procurement behaviors of each buyer type.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Submission of a MAA to the MEB, with requirements similar to those of the European Medicines Agency (EMA).
Estimated Timeline: Approximately 210 days.
Import Tariff/Duty: As part of the EU, the Netherlands applies a 0% duty for HS Code 30049049.
Poland:
Regulatory Authority: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
Import Registration Process: MAA submission to URPL, aligning with EU directives.
Estimated Timeline: Approximately 210 days.
Import Tariff/Duty: As an EU member, Poland applies a 0% duty for HS Code 30049049.
Pakistan:
Regulatory Authority: Drug Regulatory Authority of Pakistan (DRAP).
Import Registration Process: Submission of a registration dossier to DRAP, including product details, manufacturing information, and clinical data.
Estimated Timeline: 6 to 12 months, depending on the product category.
Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are typically subject to a 5% customs duty, with potential exemptions for essential medicines.
Venezuela:
Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).
Import Registration Process: Submission of a sanitary registration application to INHRR, including quality, safety, and efficacy data.
Estimated Timeline: 12 to 18 months, subject to regulatory review processes.
Import Tariff/Duty: Pharmaceutical imports may be subject to duties ranging from 5% to 15%, depending on the product classification and trade agreements.
Navigating these regulatory landscapes requires thorough preparation and compliance with each country's specific requirements to ensure successful market entry.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many countries utilize competitive tendering processes for pharmaceutical procurement. This approach can lead to increased demand for Vinorelbine, as suppliers compete to offer the best value for large-scale purchases.
With 138 buyers across 60 countries, the global demand for Vinorelbine reflects a combination of disease burden, healthcare policy initiatives, and procurement strategies aimed at enhancing cancer treatment accessibility.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 138 global importers of Vinorelbine identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 439 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 60 destination countries with market share per buyer calculated from capped values.
